Taysha Gene Therapies, Inc.

NASDAQ:TSHA

Biotechnology

Healthcare
$3.77 +1.53%

+$0.10 today

Market cap
$1.22B
Beta
1.18
P/E (TTM)
-17.7
EPS (TTM)
-$0.35
52W Low $2.25High $7.30

Volume 2.17M

Average 2.73M

Private 5-step workspace

Build a TSHA investment thesis

Turn Taysha Gene Therapies, Inc. research into a structured decision across business quality, moat, management, intrinsic value, and synthesis.

Log in to save your stock analysis
Your answers are private and saved per stock, so you can come back to the thesis later.